Filing Details

Accession Number:
0001438133-20-000009
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-31 18:28:55
Reporting Period:
2020-01-29
Accepted Time:
2020-01-31 18:28:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM Surgical & Medical Instruments & Apparatus (3841) 204327508
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1582779 Dick Allen C/O Tandem Diabetes Care, Inc.,
11075 Roselle Street
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-01-29 1,671 $11.06 1,671 No 4 M Direct
Common Stock Disposition 2020-01-29 1,671 $75.56 0 No 4 S Direct
Common Stock Acquisiton 2020-01-29 1,700 $19.00 1,700 No 4 M Direct
Common Stock Disposition 2020-01-29 1,700 $76.00 0 No 4 S Direct
Common Stock Acquisiton 2020-01-29 5,300 $2.59 5,300 No 4 M Direct
Common Stock Disposition 2020-01-29 5,300 $75.95 0 No 4 S Direct
Common Stock Acquisiton 2020-01-29 1,700 $2.54 1,700 No 4 M Direct
Common Stock Disposition 2020-01-29 1,700 $76.15 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Stock Option Common Stock Disposition 2020-01-29 1,671 $0.00 1,671 $11.06
Stock Option Common Stock Disposition 2020-01-29 1,700 $0.00 1,700 $19.00
Stock Option Common Stock Disposition 2020-01-29 5,300 $0.00 5,300 $2.59
Stock Option Common Stock Disposition 2020-01-29 1,700 $0.00 1,700 $2.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
0 No 4 M Direct
0 No 4 M Direct
0 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 37,000 Indirect See Footnote
Common Stock 1,500 Indirect See Footnotes
Common Stock 1,500 Indirect See Footnote(s)
Common Stock 10,000 Indirect See Footnotes)
Footnotes
  1. Represents shares of common stock received upon exercise of a stock option award.
  2. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person August 22, 2019.
  3. The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $75.29 to $76.29. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  4. The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $75.73 to $76.48. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  5. The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $75.87 to $76.10. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  6. The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $76.06 to $76.54. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  7. The securities are held by the Allen Family Trust dated October 12, 1981.
  8. The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon.
  9. The securities are held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon.
  10. The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein.
  11. The option shall vest in equal monthly installments for a period of twenty-four(24) months.
  12. The expiration date for these options is 10 years from the date of grant.
  13. The option vested in twelve (12) equal monthly installments after one year from grant.